Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 407

1.

Genetic diversity of hepatitis D virus genotype-1 in Europe allows classification into subtypes.

Karimzadeh H, Usman Z, Frishman D, Roggendorf M.

J Viral Hepat. 2019 Feb 23. doi: 10.1111/jvh.13086. [Epub ahead of print]

PMID:
30801877
2.

Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level.

Karimzadeh H, Kiraithe MM, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze Zur Wiesch J, Budeus B, Hoffmann D, Wedemeyer H, Cornberg M, Krawczyk A, Rashidi-Alavijeh J, Rodríguez-Frías F, Casillas R, Buti M, Smedile A, Alavian SM, Heinold A, Emmerich F, Panning M, Gostick E, Price DA, Timm J, Hofmann M, Raziorrouh B, Thimme R, Protzer U, Roggendorf M, Neumann-Haefelin C.

Gastroenterology. 2019 May;156(6):1820-1833. doi: 10.1053/j.gastro.2019.02.003. Epub 2019 Feb 12.

3.

Induction of herpes simplex virus type 1 cell-to-cell spread inhibiting antibodies by a calcium phosphate nanoparticle-based vaccine.

Kopp M, Aufderhorst UW, Alt M, Dittmer U, Eis-Hübinger AM, Giebel B, Roggendorf M, Epple M, Krawczyk A.

Nanomedicine. 2019 Feb;16:138-148. doi: 10.1016/j.nano.2018.12.002. Epub 2018 Dec 27.

4.

Variants of hepatitis B virus surface antigen observed during therapy with nucleic acid polymer REP 2139-Ca have no influence on treatment outcome and its detection by diagnostic assays.

Mijočević H, Karimzadeh H, Seebach J, Usman Z, Al-Mahtab M, Bazinet M, Vaillant A, Roggendorf M.

J Viral Hepat. 2019 Apr;26(4):485-495. doi: 10.1111/jvh.13044. Epub 2018 Dec 27.

PMID:
30450662
5.

Impact of endodontic post material on longitudinal changes in interproximal bone level: a randomized controlled pilot trial.

von Stein-Lausnitz M, von Stein-Lausnitz A, Reissmann DR, Roggendorf MJ, Beuer F, Naumann M, Sterzenbach G.

Clin Oral Investig. 2019 May;23(5):2303-2311. doi: 10.1007/s00784-018-2698-1. Epub 2018 Oct 6.

PMID:
30293188
6.

Corrigendum to "Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection" [Virology 512 (2017) 194-200].

Bauer D, Keller J, Alt M, Schubert A, Aufderhorst UW, Palapys V, Kasper M, Heilingloh CS, Dittmer U, Laffer B, Eis-Hübinger AM, Verjans GM, Heiligenhaus A, Roggendorf M, Krawczyk A.

Virology. 2019 Jan 2;526:231-232. doi: 10.1016/j.virol.2018.09.012. Epub 2018 Oct 2. No abstract available.

PMID:
30290967
7.

Patients' self-report on post-retained restoration is more valuable than expected! Explorative analysis of an 11-year follow-up.

von Stein-Lausnitz M, Reissmann DR, Roggendorf MJ, Sterzenbach G, Naumann M.

Acta Odontol Scand. 2018 Aug 29:1-6. doi: 10.1080/00016357.2018.1497804. [Epub ahead of print]

PMID:
30156134
8.

Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccination.

Dembek C, Protzer U, Roggendorf M.

Curr Opin Virol. 2018 Jun;30:58-67. doi: 10.1016/j.coviro.2018.04.003. Epub 2018 May 8. Review.

PMID:
29751272
9.

Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells.

Karimzadeh H, Kiraithe MM, Kosinska AD, Glaser M, Fiedler M, Oberhardt V, Salimi Alizei E, Hofmann M, Mok JY, Nguyen M, van Esch WJE, Budeus B, Grabowski J, Homs M, Olivero A, Keyvani H, Rodríguez-Frías F, Tabernero D, Buti M, Heinold A, Alavian SM, Bauer T, Schulze Zur Wiesch J, Raziorrouh B, Hoffmann D, Smedile A, Rizzetto M, Wedemeyer H, Timm J, Antes I, Neumann-Haefelin C, Protzer U, Roggendorf M.

J Virol. 2018 Jun 13;92(13). pii: e01891-17. doi: 10.1128/JVI.01891-17. Print 2018 Jul 1.

10.

TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production.

Liu J, Yu Q, Wu W, Huang X, Broering R, Werner M, Roggendorf M, Yang D, Lu M.

J Immunol. 2018 Apr 1;200(7):2341-2351. doi: 10.4049/jimmunol.1700540. Epub 2018 Feb 19.

11.

A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease.

Bauer D, Alt M, Dirks M, Buch A, Heilingloh CS, Dittmer U, Giebel B, Görgens A, Palapys V, Kasper M, Eis-Hübinger AM, Sodeik B, Heiligenhaus A, Roggendorf M, Krawczyk A.

Front Microbiol. 2017 Oct 31;8:2115. doi: 10.3389/fmicb.2017.02115. eCollection 2017.

12.

Activity of nucleic acid polymers in rodent models of HBV infection.

Schöneweis K, Motter N, Roppert PL, Lu M, Wang B, Roehl I, Glebe D, Yang D, Morrey JD, Roggendorf M, Vaillant A.

Antiviral Res. 2018 Jan;149:26-33. doi: 10.1016/j.antiviral.2017.10.022. Epub 2017 Nov 8.

13.

Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections.

Bauer D, Keller J, Alt M, Schubert A, Aufderhorst UW, Palapys V, Kasper M, Heilingloh CS, Dittmer U, Laffer B, Eis-Hübinger AM, Verjans GM, Heiligenhaus A, Roggendorf M, Krawczyk A.

Virology. 2017 Dec;512:194-200. doi: 10.1016/j.virol.2017.09.021. Epub 2017 Oct 3. Erratum in: Virology. 2019 Jan 2;526:231-232.

14.

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.

Bazinet M, Pântea V, Cebotarescu V, Cojuhari L, Jimbei P, Albrecht J, Schmid P, Le Gal F, Gordien E, Krawczyk A, Mijočević H, Karimzadeh H, Roggendorf M, Vaillant A.

Lancet Gastroenterol Hepatol. 2017 Dec;2(12):877-889. doi: 10.1016/S2468-1253(17)30288-1. Epub 2017 Sep 28. Erratum in: Lancet Gastroenterol Hepatol. 2018 Jan;3(1):e1.

PMID:
28964701
15.

Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.

Kosinska AD, Pishraft-Sabet L, Wu W, Fang Z, Lenart M, Chen J, Dietze KK, Wang C, Kemper T, Lin Y, Yeh SH, Liu J, Dittmer U, Yuan Z, Roggendorf M, Lu M.

Hepatology. 2017 Jul;66(1):69-83. doi: 10.1002/hep.29155. Epub 2017 May 26.

PMID:
28295453
16.

Molecular cloning, characterization and expression analysis of Tim-3 and Galectin-9 in the woodchuck model.

Liu Y, Wang J, Wang L, Wang B, Yang S, Wang Q, Luo J, Feng X, Yang X, Lu Y, Roggendorf M, Lu M, Yang D, Liu J.

Mol Immunol. 2017 Mar;83:127-136. doi: 10.1016/j.molimm.2017.01.018. Epub 2017 Jan 30.

PMID:
28152393
17.

Transcriptome Analysis and Comparison of Marmota monax and Marmota himalayana.

Liu Y, Wang B, Wang L, Vikash V, Wang Q, Roggendorf M, Lu M, Yang D, Liu J.

PLoS One. 2016 Nov 2;11(11):e0165875. doi: 10.1371/journal.pone.0165875. eCollection 2016.

18.

Shear Bond Strength of Three Orthodontic Bonding Systems on Enamel and Restorative Materials.

Hellak A, Ebeling J, Schauseil M, Stein S, Roggendorf M, Korbmacher-Steiner H.

Biomed Res Int. 2016;2016:6307107. Epub 2016 Sep 21.

19.

Molecular cloning, characterization and expression analysis of TGF-β and receptor genes in the woodchuck model.

Wang L, Wang J, Liu Y, Wang B, Yang S, Yu Q, Roggendorf M, Lu M, Liu J, Yang D.

Gene. 2016 Dec 20;595(1):1-8. doi: 10.1016/j.gene.2016.09.018. Epub 2016 Sep 13.

PMID:
27637515
20.

Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection.

Homs M, Rodriguez-Frias F, Gregori J, Ruiz A, Reimundo P, Casillas R, Tabernero D, Godoy C, Barakat S, Quer J, Riveiro-Barciela M, Roggendorf M, Esteban R, Buti M.

PLoS One. 2016 Jun 30;11(6):e0158557. doi: 10.1371/journal.pone.0158557. eCollection 2016.

21.

Shear bond strength and debonding characteristics of a new premixed self-etching with a reference total-etch adhesive.

Schauseil M, Blöcher S, Hellak A, Roggendorf MJ, Stein S, Korbmacher-Steiner H.

Head Face Med. 2016 Apr 30;12(1):19. doi: 10.1186/s13005-016-0117-x.

22.

Clearance of HBV DNA in immunized children born to HBsAg-positive mothers, years after being diagnosed with occult HBV infection.

Sadeghi A, Yahyapour Y, Poortahmasebi V, Shahmoradi S, Roggendorf M, Karimzadeh H, Alavian SM, Jazayeri SM.

J Viral Hepat. 2016 Apr;23(4):282-5. doi: 10.1111/jvh.12490. Epub 2015 Nov 24.

PMID:
26598112
23.

Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection.

Meng Z, Zhang X, Pei R, Zhang E, Kemper T, Vollmer J, Davis HL, Glebe D, Gerlich W, Roggendorf M, Lu M.

Antiviral Res. 2016 Jan;125:14-24. doi: 10.1016/j.antiviral.2015.11.001. Epub 2015 Nov 14.

PMID:
26585244
24.

The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

Roggendorf M, Kosinska AD, Liu J, Lu M.

Cold Spring Harb Perspect Med. 2015 Oct 28;5(12). pii: a021451. doi: 10.1101/cshperspect.a021451. Review.

25.

Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors.

Lindemann M, Koldehoff M, Fiedler M, Schumann A, Ottinger HD, Heinemann FM, Roggendorf M, Horn PA, Beelen DW.

Bone Marrow Transplant. 2016 Mar;51(3):428-31. doi: 10.1038/bmt.2015.253. Epub 2015 Oct 26. No abstract available.

PMID:
26501767
26.

Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA.

Zhang E, Kosinska A, Lu M, Yan H, Roggendorf M.

Antiviral Res. 2015 Nov;123:193-203. doi: 10.1016/j.antiviral.2015.10.009. Epub 2015 Oct 22. Review.

PMID:
26476376
27.

Stability of endodontically treated teeth with differently invasive restorations: Adhesive vs. non-adhesive cusp stabilization.

Frankenberger R, Zeilinger I, Krech M, Mörig G, Naumann M, Braun A, Krämer N, Roggendorf MJ.

Dent Mater. 2015 Nov;31(11):1312-20. doi: 10.1016/j.dental.2015.08.160. Epub 2015 Sep 26.

PMID:
26411645
28.

Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantation.

Schumann A, Fiedler M, Beckebaum S, Cicinnati VR, Herzer K, Lenz V, Witzke O, Paul A, Roggendorf M, Horn PA, Lindemann M.

Hum Immunol. 2015 Sep;76(9):631-5. doi: 10.1016/j.humimm.2015.09.008. Epub 2015 Sep 21.

PMID:
26394233
29.

Performance characteristics of the VERSANT hepatitis C virus RNA 1.0 (kPCR) assay.

Grüner N, Viazov S, Korn K, Knöll A, Trippler M, Schlaak JF, Gerken G, Roggendorf M, Ross RS.

Int J Med Microbiol. 2015 Oct;305(7):627-35. doi: 10.1016/j.ijmm.2015.08.012. Epub 2015 Aug 21.

PMID:
26384868
30.

Instructive even after a decade: Complete results of initial virological diagnostics and re-evaluation of molecular data in the German rabies virus "outbreak" caused by transplantations.

Ross RS, Wolters B, Hoffmann B, Geue L, Viazov S, Grüner N, Roggendorf M, Müller T.

Int J Med Microbiol. 2015 Oct;305(7):636-43. doi: 10.1016/j.ijmm.2015.08.013. Epub 2015 Aug 21.

PMID:
26384867
31.

Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.

Tawar RG, Colpitts CC, Timm J, Fehm T, Roggendorf M, Meisel H, Meyer N, Habersetzer F, Cosset FL, Berg T, Zeisel MB, Baumert TF.

Hepatology. 2015 Sep;62(3):726-36. doi: 10.1002/hep.27906. Epub 2015 Jul 28.

PMID:
26010076
32.

TLR ligand induced IL-6 counter-regulates the anti-viral CD8(+) T cell response during an acute retrovirus infection.

Wu W, Dietze KK, Gibbert K, Lang KS, Trilling M, Yan H, Wu J, Yang D, Lu M, Roggendorf M, Dittmer U, Liu J.

Sci Rep. 2015 May 21;5:10501. doi: 10.1038/srep10501.

33.

Adhesive luting of new CAD/CAM materials.

Frankenberger R, Hartmann VE, Krech M, Krämer N, Reich S, Braun A, Roggendorf M.

Int J Comput Dent. 2015;18(1):9-20. English, German.

PMID:
25911826
34.

Effect on enamel shear bond strength of adding microsilver and nanosilver particles to the primer of an orthodontic adhesive.

Blöcher S, Frankenberger R, Hellak A, Schauseil M, Roggendorf MJ, Korbmacher-Steiner HM.

BMC Oral Health. 2015 Mar 25;15:42. doi: 10.1186/s12903-015-0024-8.

35.

Apical debris removal of CanalBrushes with different tip modifications.

Roggendorf MJ, Kraus F, Lohbauer U, Frankenberger R, Petschelt A, Ebert J.

Quintessence Int. 2015 Nov-Dec;46(10):853-60. doi: 10.3290/j.qi.a33687.

PMID:
25699297
36.

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy.

Daram M, Montazeri G, Karimzadeh H, Malekzadeh R, Mahmoodi M, Goodarzi Z, Keyvani H, Mirmomen S, Alavian SM, Roggendorf M, Jazayeri SM.

Iran J Basic Med Sci. 2014 Sep;17(9):638-45.

37.

Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.

Kefalakes H, Jochum C, Hilgard G, Kahraman A, Bohrer AM, El Hindy N, Heinemann FM, Verheyen J, Gerken G, Roggendorf M, Timm J.

J Hepatol. 2015 Jul;63(1):13-9. doi: 10.1016/j.jhep.2015.01.030. Epub 2015 Jan 31.

PMID:
25646888
38.

Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.

Krawczyk A, Dirks M, Kasper M, Buch A, Dittmer U, Giebel B, Wildschütz L, Busch M, Goergens A, Schneweis KE, Eis-Hübinger AM, Sodeik B, Heiligenhaus A, Roggendorf M, Bauer D.

PLoS One. 2015 Jan 14;10(1):e0116800. doi: 10.1371/journal.pone.0116800. eCollection 2015.

39.

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.

Shouval D, Roggendorf H, Roggendorf M.

Med Microbiol Immunol. 2015 Feb;204(1):57-68. doi: 10.1007/s00430-014-0374-x. Epub 2015 Jan 4. Review.

40.

Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.

Kosinska AD, Liu J, Lu M, Roggendorf M.

Med Microbiol Immunol. 2015 Feb;204(1):103-14. doi: 10.1007/s00430-014-0379-5. Epub 2014 Dec 23. Review.

41.

Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects.

Zhang E, Kosinska AD, Ma Z, Dietze KK, Xu Y, Meng Z, Zhang X, Wang J, Wang B, Dittmer U, Roggendorf M, Yang D, Lu M.

Virology. 2015 Jan 15;475:56-65. doi: 10.1016/j.virol.2014.11.004. Epub 2014 Nov 25.

42.

Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96.

Pishraft-Sabet L, Kosinska AD, Rafati S, Bolhassani A, Taheri T, Memarnejadian A, Alavian SM, Roggendorf M, Samimi-Rad K.

Arch Virol. 2015 Jan;160(1):141-52. doi: 10.1007/s00705-014-2243-8. Epub 2014 Oct 28.

PMID:
25348271
43.

Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.

Lange M, Fiedler M, Bankwitz D, Osburn W, Viazov S, Brovko O, Zekri AR, Khudyakov Y, Nassal M, Pumpens P, Pietschmann T, Timm J, Roggendorf M, Walker A.

PLoS One. 2014 Jul 11;9(7):e102235. doi: 10.1371/journal.pone.0102235. eCollection 2014.

44.

Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.

Krawczyk A, Ludwig C, Jochum C, Fiedler M, Heinemann FM, Shouval D, Roggendorf M, Roggendorf H, Lindemann M.

Vaccine. 2014 Sep 3;32(39):5077-82. doi: 10.1016/j.vaccine.2014.06.076. Epub 2014 Jun 24.

PMID:
24975813
45.

Genetic heterogeneity of hepatitis C virus cell entry receptors seems to have no influence on selection of virus variants.

Lipskoch M, Wiese M, Timm J, Roggendorf M, Viazov S.

Virol J. 2014 Mar 14;11:50. doi: 10.1186/1743-422X-11-50.

46.

New therapeutic vaccination strategies for the treatment of chronic hepatitis B.

Liu J, Kosinska A, Lu M, Roggendorf M.

Virol Sin. 2014 Feb;29(1):10-6. doi: 10.1007/s12250-014-3410-5. Epub 2014 Jan 17. Review.

PMID:
24452539
47.

Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.

Liu J, Zhang E, Ma Z, Wu W, Kosinska A, Zhang X, Möller I, Seiz P, Glebe D, Wang B, Yang D, Lu M, Roggendorf M.

PLoS Pathog. 2014 Jan;10(1):e1003856. doi: 10.1371/journal.ppat.1003856. Epub 2014 Jan 2.

48.

Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins.

Meng Z, Ma Z, Zhang E, Kosinska AD, Liu J, Zhang X, Zhou T, Wu J, Dahmen U, Dirsch O, Yang D, Roggendorf M, Lu M.

J Virol. 2014 Feb;88(3):1573-81. doi: 10.1128/JVI.02086-13. Epub 2013 Nov 20.

49.

TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro.

Liu J, Jiang M, Ma Z, Dietze KK, Zelinskyy G, Yang D, Dittmer U, Schlaak JF, Roggendorf M, Lu M.

J Immunol. 2013 Dec 15;191(12):6178-90. doi: 10.4049/jimmunol.1301262. Epub 2013 Nov 13.

50.

Retrospective evaluation of perforation repairs in 6 private practices.

Pontius V, Pontius O, Braun A, Frankenberger R, Roggendorf MJ.

J Endod. 2013 Nov;39(11):1346-58. doi: 10.1016/j.joen.2013.08.006. Epub 2013 Sep 20.

PMID:
24139253

Supplemental Content

Loading ...
Support Center